Nirsevimab gets Promising Innovative Medicine Designation from MHRA EP News Bureau Jan 19, 2021 Nirsevimab is an innovative monoclonal antibody in Phase 2 and Phase 3 trials for the prevention of respiratory syncytial virus…
